ZimVie (ZIMV) Total Debt to Capital

ZimVie Inc. (ZIMV) - corporate logo

ZimVie Inc. production capacities are operating at maximum efficiency while undergoing technical modernization. The leverage ratio—total debt to equity—on the GURU.Markets historical chart reflects debt dynamics, where 0.55 determines the current value of the metric. Management aims to optimize the portfolio to drive profit growth, yet high debt leverage and pressure from insurers remain key risks for the business.

ZIMV: zimvie.com Debt to Equity Ratio 04/28/2023 - 11/01/2025

Analytical breakdowns for ZimVie Inc.

- price and consensus price forecast:
Price Chart ZimVie|ZIMV - Consensus Target
- market capitalization details:
Market Capitalization ZimVie|ZIMV - Total Enterprise Value
- book capitalization indicators:
Book Value per Share ZimVie|ZIMV - Accounting Capitalization|Market Capitalization to Book Value Ratio zimvie.com|ZIMV - Company Total Asset Base
- issuer credit burden and liquidity indicators:
Total Debt to Capital ZimVie Inc.|ZIMV - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital ZimVie Inc.|ZIMV - Company Aggregate Debts|Debt to Book Capitalization Ratio ZimVie|ZIMV - Company Long-Term Debt|Company Current Liabilities ZimVie|Quick Ratio zimvie.com
- earnings and valuation multiples information:
ZIMV - Net Financial Result
Basic company analysis:ZIMV, ZimVie
Finished products of ZimVie Corp

The total debt-to-equity ratio determines the extent of a business's financial dependence on borrowed funds relative to its own resources. By analyzing changes in the total debt-to-equity level, an investor assesses the balance between leverage and financial stability. This metric compares total liabilities with shareholder equity to identify default risks. For ZimVie Inc. (ZIMV), moderate leverage is justified by stable demand for implants. High clinic loyalty ensures a predictable cash flow for debt servicing.

Key competitors

Debt to Equity Intuitive|Total Debt to Equity Ratio Danaher Corporation (DHR)|Total Debt to Capital BDX|STE - Debt to Capital|Total Debt to Capital WST (West Pharmaceutical Services)|BAX: Debt to Equity Ratio|Masimo - Total Debt to Capital|Total Debt to Capital Coefficient Stevanato Group SpA STVN|TFX: Total Debt to Capital|Total Debt to Equity Ratio Merit Medical Corp|NVST (Envista Holdings) - Total Debt to Capital|Total Debt to Capital icumed.com|Debt to Equity Dentsply Sirona (XRAY)|Debt to Equity LMAT (LeMaitre Vascular Inc)|AtriCure Corp - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio STAA|ChromaDex Corp. - Total Debt to Capital|Total Debt to Capital Coefficient angiodynamics.com ANGO|Cerus (CERS) - Debt to Equity|Debt to Equity Ratio TKNO|Debt to Equity Monogram Technologies Inc|Sharps Tech (STSS) - Total Debt to Capital Coefficient|Total Debt to Equity Ratio INFU (InfuSystem Holdings)|Aggregate Debt to Capital UTMD|Debt to Equity KORU Medical KRMD|All Debt to Shareholders' Equity Ratio NYXH|MBOT: Total Debt to Equity Ratio|PDEX - Total Debt to Capital|Zentek Ltd. (ZTEK) - Debt to Equity|Total Debt to Equity Ratio elutia.com|MLSS (Milestone Scientific Inc.) - Total Debt to Capital|Debt to Capital NEXGEL Inc. NXGL|Debt to Equity Retractable Technologies (RVP)|harvardbioscience.com - Debt to Equity Ratio|Femasys Inc. - Total Debt to Equity Ratio|Aggregate Debt to Capital MHUA (Meihua Medical Technologies)|POAI - Debt to Equity|Total Debt to Capital Coefficient Callan JMB Inc CJMB|ATRI (Atrion Corp) - Total Debt to Equity Ratio|Aggregate Debt to Equity NURO (NeuroMetrix Corporation)